Position in HLN
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$10
New position
Shares Held
1
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0%
Shared 100%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Ameritas Investment Partners, Inc. holds $18,421,025 across 38 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
7,812 | $4,232,775 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
18,489 | $3,116,136 | |
| 3 | ELAN |
Elanco Animal Health Inc
|
91,918 | $2,262,101 | |
| 4 | HIMS |
Hims & Hers Health, Inc.
|
58,617 | $2,032,251 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
|
17,912 | $1,987,157 | |
| 6 | ALKS |
Alkermes plc.
|
15,222 | $797,632 | |
| 7 | LQDA |
Liquidia Corp
|
6,406 | $510,750 | |
| 8 | INDV |
Indivior Pharmaceuticals, Inc.
|
10,887 | $446,693 |
All Filings in HLN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10 | 1 | Shares | Sole | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||